The net sales of Essity declined 2.2 per cent to SEK 36,274 million (~$3.42 million) in the third quarter of fiscal 2024, but organic growth reached 1.9 per cent.
Strong earnings were driven by higher volumes in health and medical products and effective cost-saving measures, resulting in good profitability despite a challenging global economy.
Strong earnings were driven by higher volumes in health and medical products and effective cost-saving measures, resulting in good profitability despite a challenging global economy.
